Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type

MIMEDX GRP INC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2024202320222021202020192018201620152014
Period End Date12/31/202412/31/202312/31/202212/31/202112/31/202012/31/201912/31/201812/31/201612/31/201512/31/2014
Net Sales348.88321.48267.84258.62248.23299.26359.11245.02187.30118.22
Grant revenue--------------------
Total Revenues348.88--267.84258.62248.23299.26359.11245.02187.30118.22
Cost of sales60.0754.6348.3243.2839.3343.0836.3932.4120.2012.67
Gross Margin288.81266.84219.53215.33208.90256.17322.73212.61167.09105.56
Amortization of intangible assets0.770.760.700.821.071.041.032.130.930.93
Research and development expenses12.3412.6722.8317.3411.7211.1415.7712.048.417.05
Acquired in-process research and development--------------------
Selling, general and administrative expenses225.09211.12208.79198.36181.02198.21258.53180.00133.3890.48
Impairment of intangible assets(0.45)----(0.05)(1.03)(0.45)--------
Gain on sale of assets--------------------
Fair value adjustment of earn-out liability--------------------
Investigation, restatement and related8.70(5.18)(12.18)(3.79)(59.47)(66.50)(51.32)------
Operating Income (Loss)58.8737.12(24.97)(5.04)(45.40)(21.16)(3.92)18.4524.367.10
Interest expense, net1.016.465.024.98------0.34--0.05
Change in fair value of investment, related party--------------------
Interest (expense) income, net--------(7.94)(4.71)----(0.09)--
Other income (expense), net(0.57)(0.03)0.00(0.02)0.000.280.53------
Amortization of debt discount--------------------
Financing expense associated with warrants issued in connection with convertible promissory note--------------------
Financing expense associated with issuance of common stock for registration rights waivers--------------------
Loss on extinguishment of debt--------(8.20)----------
Income (loss) before income tax provision57.2930.63(29.99)(10.04)(61.54)(25.59)(3.40)18.1124.287.05
Income tax (benefit) provision15.30(36.81)0.210.25(12.26)(0.01)26.586.13(5.17)0.83
Net income (loss) from continuing operations42.0067.44----------------
Income (Loss) from discontinued operations, net of tax0.42(9.21)----------------
Net Loss42.4258.23(30.20)(10.29)(49.28)(25.58)----29.45--
Accretion of redeemable common stock and common stock with registration rights to fair value--6.756.586.14------------
Preferred share repurchase in excess of book value--4.89----------------
Net Income (Loss) Available to Common Shareholders42.4246.59(36.78)(16.42)(49.28)(25.58)(29.98)11.9729.456.22
Basic net income (loss) per common share:Continuing operations0.29------------------
Basic net income (loss) per common share:Discontinued operations0.00------------------
Net Earnings Per Share (Basic)0.290.40(0.33)(0.15)(0.77)(0.24)(0.28)0.110.280.06
Diluted net income (loss) per common share:Continuing operations0.28------------------
Diluted net income (loss) per common share:Discontinued operations0.00------------------
Net Earnings Per Share (Diluted)0.280.37(0.33)(0.15)(0.77)(0.24)(0.28)0.110.260.05
Weighted Average Shares Outstanding (Basic)146.98116.50112.91110.35108.26106.95105.60105.93105.93105.79
Weighted Average Shares Outstanding (Diluted)149.05145.96112.91110.35108.26106.95105.60112.44113.63113.30